EUVIMEDEUVIMED entdecken
Crossref

Effects of long‐term desmopressin treatment for nocturia in older people

Hirofumi Kurose iD, Kosuke Ueda iD, Katsuaki Chikui, Keiichiro Uemura, Kiyoaki Nishihara, Makoto Nakiri iD, Shigetaka Suekane iD, Tsukasa Igawa

International Journal of Urology · 2024

DOI: 10.1111/iju.15530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2024. Verfasst von Hirofumi Kurose und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Chikugo City Hospital, Chikugo, Fukoka, Japan. Hauptthemen laut MEDLINE: Nocturia, Deamino Arginine Vasopressin, Antidiuretic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Desmopressin improves nocturia frequency; however, reports on its long‐term efficacy and safety are few, and concerns regarding its effect on body composition exist. We thus investigated the efficacy and safety of long‐term desmopressin administration and its effect on body composition.

Methods

This retrospective study, conducted at Chikugo City Hospital between August 2020 and December 2022, involved 133 men (mean age, 77.7 years) with nocturnal and persistent nocturia, who were administered an initial dose of 50 μg desmopressin. Efficacy endpoints included nocturnal urinary frequency, nocturnal urinary volume, hours of undisturbed sleep, nocturnal polyuria index, initial nocturnal urinary volume, and daily urinary frequency in a frequency‐volume chart (3 days), before treatment and at 1, 4, 12, 24, and 52 weeks after desmopressin administration. Additionally, the effects of desmopressin on body composition were examined, including blood–brain natriuretic peptide and a chest radiography, before and 52 weeks after administration.

Results

Treatment improved most efficacy endpoint evaluation parameters. Around 87.6% of patients showed improved symptoms after 52 weeks compared with those before treatment (score ≤ 3). The blood–brain natriuretic peptide level rose; however, cardiothoracic ratio was unchanged.

Conclusion

Long‐term administration of desmopressin is thus effective and safe in older people with nocturnal polyuria, with little effect on body composition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NocturiaDeamino Arginine VasopressinAntidiuretic AgentsHumansMaleAgedRetrospective StudiesAged, 80 and overTreatment OutcomeBody CompositionTime Factors

Stichwörter der Autor:innen

body compositiondesmopressinlong‐term desmopressinnocturianocturnal polyuria

Substanzen

Deamino Arginine VasopressinAntidiuretic Agents

Autor:innen und Institutionen

  • Department of Urology, Chikugo City Hospital, Chikugo, Fukoka, Japan.
  • Department of Urology, Kurume University School of Medicine, Kurume, Fukoka, Japan.

ORCID-Profile: Hirofumi Kurose, Kosuke Ueda, Makoto Nakiri, Shigetaka Suekane

Zitieren

APA

Kurose, H., Ueda, K., Chikui, K., Uemura, K., Nishihara, K., Nakiri, M., Suekane, S., & Igawa, T. (2024). Effects of long‐term desmopressin treatment for nocturia in older people. International Journal of Urology. https://doi.org/10.1111/iju.15530

Vancouver

Kurose H, Ueda K, Chikui K, Uemura K, Nishihara K, Nakiri M, et al. Effects of long‐term desmopressin treatment for nocturia in older people. International Journal of Urology. 2024. doi:10.1111/iju.15530

BibTeX
@article{Kurose2024,
  author = {Kurose, Hirofumi and Ueda, Kosuke and Chikui, Katsuaki and Uemura, Keiichiro and Nishihara, Kiyoaki and Nakiri, Makoto and Suekane, Shigetaka and Igawa, Tsukasa},
  title = {Effects of long‐term desmopressin treatment for nocturia in older people},
  journal = {International Journal of Urology},
  year = {2024},
  doi = {10.1111/iju.15530}
}
Kostenlos starten →